
Elvina Almuradova/LinkedIn
Apr 22, 2025, 06:40
Elvina Almuradova: Trodelvy plus Keytruda Boosts PFS in PD-L1+ mTNBC Patients
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a post on X:
“Trodelvy plus Keytruda shows significant PFS benefit vs chemo plus Keytruda in 1L PD-L1+ mTNBC (ASCENT-04).
First Phase 3 trial proving TROP-2 ADC plus IO combo superiority. Early OS benefit observed.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 22, 2025, 12:05
Apr 22, 2025, 10:11
Apr 22, 2025, 10:03
Apr 22, 2025, 09:55